The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...
A new research paper was published in Volume 16, Issue 22  of Aging (Aging-US) on December 20, 2024, titled, “Impaired renal ...
The following is a summary of “Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease,” published in the January 2025 issue of ...
Around one in seven adults in the United States have chronic kidney disease (CKD), a condition in which the kidneys become ...
Taking charge of your health is one of the most powerful choices you can make, and prioritising your kidneys plays a vital ...
The following is a summary of “Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD,” ...